Beckley Psytech leads a new project focused on addressing  psychiatric and neurological conditions through the use of psychedelic medicines.

BDSI readies liquid migraine medicine launch but stays away from ‘broad blast’ marketing campaign sharon.coey Mon, 01/24/2022 – […]

AbbVie’s Skyrizi nabs psoriatic arthritis nod, its second, shortly after Rinvoq fkansteiner Mon, 01/24/2022 – 09:03

With omicron on the prowl, FDA extends inspection pause into February fkansteiner Mon, 01/24/2022 – 10:01

Gilead pulls 2 cancer accelerated approvals as changing lymphoma landscape disrupts confirmatory trial aliu Mon, 01/24/2022 – 11:34

This editorial by Peter Doshi and colleagues (BMJ 2022;376:o102, doi:10.1136/bmj.o102) originally stated that the Medicines and Healthcare Products Regulatory Agency (MHRA) […]

Less selling, more science can best help doctors navigate complex new cancer treatments, report suggests nmissakian Sun, 01/23/2022 […]

Updated Date: Fri, 14 Jan 2022 00:00:00 EST

New MRI technology, developed by Siemens in collaboration with researchers at The Ohio State University College of Medicine […]

It is important that multiple sclerosis is diagnosed and treated as early as possible in order to delay […]